The aryl hydrocarbon receptor: An environmental effector in the pathogenesis of fibrosis
Authors:
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 160, 105180
Abstract
No abstract availableKeywords
Funding Information
- National Development and Reform Commission (2019412)
- Hunan Provincial Innovation Foundation for Postgraduate (CX20190158)
- Development and Reform Commission of Hunan Province
- National Natural Science Foundation of China (81773333)
This publication has 104 references indexed in Scilit:
- Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populationsEuropean Journal of Human Genetics, 2012
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- The Aryl Hydrocarbon Receptor Ligand ITE Inhibits TGFβ1-Induced Human Myofibroblast DifferentiationThe American Journal of Pathology, 2011
- Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healingEMBO Reports, 2010
- The Uremic Toxin 3-Indoxyl Sulfate Is a Potent Endogenous Agonist for the Human Aryl Hydrocarbon ReceptorBiochemistry, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Timing is everything: Consequences of transient and sustained AhR activityBiochemical Pharmacology, 2009
- The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathwaysBiochemical Pharmacology, 2009
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- The Search for Endogenous Activators of the Aryl Hydrocarbon ReceptorChemical Research in Toxicology, 2007